{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:53:50Z","timestamp":1794887630010,"version":"4.9.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T00:00:00Z","timestamp":1442793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council (BE)","doi-asserted-by":"publisher","award":["AdvG-2012-321670"],"award-info":[{"award-number":["AdvG-2012-321670"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek (BE)","doi-asserted-by":"publisher","award":["Senior Clinical Investigator Fellowship"],"award-info":[{"award-number":["Senior Clinical Investigator Fellowship"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Methusalem Program","award":["METH\/08\/07"],"award-info":[{"award-number":["METH\/08\/07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00134-015-4054-0","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T07:39:52Z","timestamp":1442821192000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Cholestatic liver (dys)function during sepsis and other critical illnesses"],"prefix":"10.1007","volume":"42","author":[{"given":"Marc","family":"Jenniskens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Langouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Mee","family":"Vanwijngaerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Mesotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Van den Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"key":"4054_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc11381","volume":"16","author":"N Nesseler","year":"2012","unstructured":"Nesseler N, Launey Y, Aninat C, Morel F, Mall\u00e9dant Y, Seguin P (2012) Clinical review: the liver in sepsis. Crit Care 16:235","journal-title":"Crit Care"},{"key":"4054_CR2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.CCM.0000259462.97164.A0","volume":"35","author":"L Kramer","year":"2007","unstructured":"Kramer L, Jordan B, Druml W, Bauer P, Metnitz PGH, Austrian Epidemiologic Study on Intensive Care ASDI Study Group (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients\u2014a prospective multicenter study. Crit Care Med 35:1099\u20131104","journal-title":"Crit Care Med"},{"key":"4054_CR3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00134-011-2248-7","volume":"37","author":"V Fuhrmann","year":"2011","unstructured":"Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Sch\u00f6niger-Hekele M, Madl C, Schenk P (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302\u20131310","journal-title":"Intensive Care Med"},{"key":"4054_CR4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00134-009-1511-7","volume":"35","author":"SJ Thomson","year":"2009","unstructured":"Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) \u2018Liver function tests\u2019 on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406\u20131411","journal-title":"Intensive Care Med"},{"key":"4054_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MCC.0b013e32835ec9e6","volume":"19","author":"T Horvatits","year":"2013","unstructured":"Horvatits T, Trauner M, Fuhrmann V (2013) Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care 19:128\u2013132","journal-title":"Curr Opin Crit Care"},{"key":"4054_CR6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1478-3231.2011.02655.x","volume":"32","author":"J Henrion","year":"2012","unstructured":"Henrion J (2012) Hypoxic hepatitis. Liver Int 32:1039\u20131052","journal-title":"Liver Int"},{"key":"4054_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00134-005-0023-3","volume":"32","author":"N Brienza","year":"2006","unstructured":"Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T (2006) Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 32:267\u2013274","journal-title":"Intensive Care Med"},{"key":"4054_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00005373-200209000-00020","volume":"53","author":"BG Harbrecht","year":"2002","unstructured":"Harbrecht BG, Zenati MS, Doyle HR, McMichael J, Townsend RN, Clancy KD, Peitzman AB (2002) Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 53:517\u2013523","journal-title":"J Trauma"},{"key":"4054_CR9","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/jc.2008-2579","volume":"94","author":"D Mesotten","year":"2009","unstructured":"Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A (2009) The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab 94:2345\u20132352","journal-title":"J Clin Endocrinol Metab"},{"key":"4054_CR10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","volume":"16","author":"VM Deursen van","year":"2010","unstructured":"van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84\u201390","journal-title":"J Card Fail"},{"key":"4054_CR11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2214\/ajr.174.4.1740973","volume":"174","author":"GW Boland","year":"2000","unstructured":"Boland GW, Slater G, Lu DS, Eisenberg P, Lee MJ, Mueller PR (2000) Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol 174:973\u2013977","journal-title":"AJR Am J Roentgenol"},{"key":"4054_CR12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/gut.33.8.1123","volume":"33","author":"FE Murray","year":"1992","unstructured":"Murray FE, Stinchcombe SJ, Hawkey CJ (1992) Development of biliary sludge in patients on intensive care unit: results of a prospective ultrasonographic study. Gut 33:1123\u20131125","journal-title":"Gut"},{"key":"4054_CR13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707\u2013710","journal-title":"Intensive Care Med"},{"key":"4054_CR14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1440-1746.1999.01982.x","volume":"14","author":"M Trauner","year":"1999","unstructured":"Trauner M, Fickert P, Stauber RE (1999) Inflammation-induced cholestasis. J Gastroenterol Hepatol 14:946\u2013959","journal-title":"J Gastroenterol Hepatol"},{"key":"4054_CR15","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/cc5670","volume":"11","author":"T Grau","year":"2007","unstructured":"Grau T, Bonet A, Rubio M, Mateo D, Farr\u00e9 M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A, Working Group on Nutrition and Metabolism of the Spanish Society of Critical Care (2007) Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 11:R10","journal-title":"Crit Care"},{"key":"4054_CR16","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1097\/CCM.0b013e3181de0db2","volume":"38","author":"I Lat","year":"2010","unstructured":"Lat I, Foster DR, Erstad B (2010) Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med 38:S175\u2013S187","journal-title":"Crit Care Med"},{"key":"4054_CR17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1194\/jlr.R024794","volume":"53","author":"G Porez","year":"2012","unstructured":"Porez G, Prawitt J, Gross B, Staels B (2012) Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 53:1723\u20131737","journal-title":"J Lipid Res"},{"key":"4054_CR18","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JYL Chiang","year":"2009","unstructured":"Chiang JYL (2009) Bile acids: regulation of synthesis. J Lipid Res 50:1955\u20131966","journal-title":"J Lipid Res"},{"key":"4054_CR19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clinre.2012.06.006","volume":"36","author":"R Kubitz","year":"2012","unstructured":"Kubitz R, Droge C, Stindt J, Weissenberger K, Haussinger D (2012) The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol 36:536\u2013553","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4054_CR20","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","volume":"24","author":"WA Alrefai","year":"2007","unstructured":"Alrefai WA, Gill RK (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 24:1803\u20131823","journal-title":"Pharm Res"},{"key":"4054_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/jhep.2001.23501","volume":"33","author":"CJ Soroka","year":"2001","unstructured":"Soroka CJ, Lee JM, Azzaroli F, Boyer JL (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783\u2013791","journal-title":"Hepatology"},{"key":"4054_CR22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2003.12.001","volume":"40","author":"GU Denk","year":"2004","unstructured":"Denk GU, Soroka CJ, Takeyama Y, Chen W-S, Schuetz JD, Boyer JL (2004) Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 40:585\u2013591","journal-title":"J Hepatol"},{"key":"4054_CR23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/gast.2001.29608","volume":"121","author":"J Lee","year":"2001","unstructured":"Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, Kramer W, Boyer JL (2001) Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121:1473\u20131484","journal-title":"Gastroenterology"},{"key":"4054_CR24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nri1748","volume":"6","author":"CK Glass","year":"2006","unstructured":"Glass CK, Ogawa S (2006) Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6:44\u201355","journal-title":"Nat Rev Immunol"},{"key":"4054_CR25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517\u2013526","journal-title":"Mol Cell"},{"key":"4054_CR26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","volume":"6","author":"TT Lu","year":"2000","unstructured":"Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507\u2013515","journal-title":"Mol Cell"},{"key":"4054_CR27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jps.20324","volume":"94","author":"RG Tirona","year":"2005","unstructured":"Tirona RG, Kim RB (2005) Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169\u20131186","journal-title":"J Pharm Sci"},{"key":"4054_CR28","doi-asserted-by":"crossref","first-page":"G349","DOI":"10.1152\/ajpgi.00417.2002","volume":"284","author":"JYL Chiang","year":"2003","unstructured":"Chiang JYL (2003) Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284:G349\u2013G356","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4054_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cld.2012.12.001","volume":"17","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Baghdasaryan A, Trauner M (2013) Nuclear receptors as drug targets in cholestatic liver diseases. Clin Liver Dis 17:161\u2013189","journal-title":"Clin Liver Dis"},{"key":"4054_CR30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1258\/acb.2010.010040","volume":"47","author":"C Glicksman","year":"2010","unstructured":"Glicksman C, Pournaras DJ, Wright M, Roberts R, Mahon D, Welbourn R, Sherwood R, Alaghband-Zadeh J, le Roux CW (2010) Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 47:482\u2013484","journal-title":"Ann Clin Biochem"},{"key":"4054_CR31","doi-asserted-by":"crossref","first-page":"e6843","DOI":"10.1371\/journal.pone.0006843","volume":"4","author":"K Ma","year":"2009","unstructured":"Ma K, Xiao R, Tseng H-T, Shan L, Fu L, Moore DD (2009) Circadian dysregulation disrupts bile acid homeostasis. PLoS One 4:e6843","journal-title":"PLoS One"},{"key":"4054_CR32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7:678\u2013693","journal-title":"Nat Rev Drug Discov"},{"key":"4054_CR33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","volume":"25","author":"SM Houten","year":"2006","unstructured":"Houten SM, Watanabe M, Auwerx J (2006) Endocrine functions of bile acids. EMBO J 25:1419\u20131425","journal-title":"EMBO J"},{"key":"4054_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","volume":"11","author":"FG Schaap","year":"2014","unstructured":"Schaap FG, Trauner M, Jansen PLM (2014) Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 11:55\u201367","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4054_CR35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ Aguiar Vallim de","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA (2013) Pleiotropic roles of bile acids in metabolism. Cell Metab 17:657\u2013669","journal-title":"Cell Metab"},{"key":"4054_CR36","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.3748\/wjg.14.5620","volume":"14","author":"V Keitel","year":"2008","unstructured":"Keitel V, Kubitz R, Haussinger D (2008) Endocrine and paracrine role of bile acids. World J Gastroenterol 14:5620\u20135629","journal-title":"World J Gastroenterol"},{"key":"4054_CR37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s005340170047","volume":"8","author":"K Hirata","year":"2001","unstructured":"Hirata K, Ikeda S, Honma T, Mitaka T, Furuhata T, Katsuramaki T, Hata F, Mukaiya M (2001) Sepsis and cholestasis: basic findings in the sinusoid and bile canaliculus. J Hepatobiliary Pancreatic Surg 8:20\u201326","journal-title":"J Hepatobiliary Pancreatic Surg"},{"key":"4054_CR38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3748\/wjg.14.1389","volume":"14","author":"J Koskinas","year":"2008","unstructured":"Koskinas J, Gomatos IP, Tiniakos DG, Memos N, Boutsikou M, Garatzioti A, Archimandritis A, Betrosian A (2008) Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol 14:1389\u20131393","journal-title":"World J Gastroenterol"},{"key":"4054_CR39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1023\/A:1017993214196","volume":"132","author":"NL Lysova","year":"2001","unstructured":"Lysova NL, Gurevich LE, Trusov OA, Shchegolev AI, Mishnev OD (2001) Immunohistochemical characteristics of the liver in patients with peritonitis (early autopsy). Bull Exp Biol Med 132:1125\u20131129","journal-title":"Bull Exp Biol Med"},{"key":"4054_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0046-8177(82)80134-2","volume":"13","author":"JH Lefkowitch","year":"1982","unstructured":"Lefkowitch JH (1982) Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and \u201ccholangitis lenta\u201d. Hum Pathol 13:19\u201324","journal-title":"Hum Pathol"},{"key":"4054_CR41","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","volume":"339","author":"M Trauner","year":"1998","unstructured":"Trauner M, Meier PJ, Boyer JL (1998) Molecular pathogenesis of cholestasis. New Engl J Med 339:1217\u20131227","journal-title":"New Engl J Med"},{"key":"4054_CR42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-2006-925241","volume":"38","author":"C Jaeger","year":"2006","unstructured":"Jaeger C, Mayer G, Henrich R, Gossner L, Rabenstein T, May A, Guenter E, Ell C (2006) Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy 38:730\u2013734","journal-title":"Endoscopy"},{"key":"4054_CR43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-967024","volume":"40","author":"H Kulaksiz","year":"2008","unstructured":"Kulaksiz H, Heuberger D, Engler S, Stiehl A (2008) Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40:214\u2013218","journal-title":"Endoscopy"},{"key":"4054_CR44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/gast.1996.v111.pm8698199","volume":"111","author":"RM Green","year":"1996","unstructured":"Green RM, Beier D, Gollan JL (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111:193\u2013198","journal-title":"Gastroenterology"},{"key":"4054_CR45","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.24582","volume":"54","author":"YM Vanwijngaerden","year":"2011","unstructured":"Vanwijngaerden YM, Wauters J, Langouche L, Vander Perre S, Liddle C, Coulter S, Vanderborght S, Roskams T, Wilmer A, Van den Berghe G, Mesotten D (2011) Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology 54:1741\u20131752","journal-title":"Hepatology"},{"key":"4054_CR46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/SHK.0b013e318150762b","volume":"29","author":"KM Andrejko","year":"2008","unstructured":"Andrejko KM, Raj NR, Kim PK, Cereda M, Deutschman CS (2008) IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock 29:490\u2013496","journal-title":"Shock"},{"key":"4054_CR47","doi-asserted-by":"crossref","first-page":"G831","DOI":"10.1152\/ajpgi.00307.2004","volume":"289","author":"A Geier","year":"2005","unstructured":"Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, Suchy FJ, Matern S, Gartung C (2005) Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289:G831\u2013G841","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4054_CR48","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.32.7.734","volume":"32","author":"NJ Cherrington","year":"2004","unstructured":"Cherrington NJ, Slitt AL, Li N, Klaassen CD (2004) Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734\u2013741","journal-title":"Drug Metab Dispos"},{"key":"4054_CR49","doi-asserted-by":"crossref","first-page":"G1008","DOI":"10.1152\/ajpgi.00071.2004","volume":"287","author":"MGL Elferink","year":"2004","unstructured":"Elferink MGL, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJH, Meijer DKF, Groothuis GMM (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008\u2013G1016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4054_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1515\/BC.2004.029","volume":"385","author":"MG Donner","year":"2004","unstructured":"Donner MG, Warskulat U, Saha N, H\u00e4ussinger D (2004) Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 385:331\u2013339","journal-title":"Biol Chem"},{"key":"4054_CR51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/SHK.0000000000000046","volume":"41","author":"Y-M Vanwijngaerden","year":"2014","unstructured":"Vanwijngaerden Y-M, Langouche L, Derde S, Liddle C, Coulter S, Van den Berghe G, Mesotten D (2014) Impact of parenteral nutrition versus fasting on hepatic bile acid production and transport in a rabbit model of prolonged critical illness. Shock 41:48\u201354","journal-title":"Shock"},{"key":"4054_CR52","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1074\/jbc.M508277200","volume":"281","author":"TL Zimmerman","year":"2006","unstructured":"Zimmerman TL, Thevananther S, Ghose R, Burns AR, Karpen SJ (2006) Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281:15434\u201315440","journal-title":"J Biol Chem"},{"key":"4054_CR53","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ncpgasthep0602","volume":"3","author":"A Geier","year":"2006","unstructured":"Geier A, Fickert P, Trauner M (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3:574\u2013585","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"4054_CR54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.48.3.409","volume":"48","author":"MW Whitehead","year":"2001","unstructured":"Whitehead MW, Hainsworth I, Kingham JG (2001) The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut 48:409\u2013413","journal-title":"Gut"},{"key":"4054_CR55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/gut.39.4.587","volume":"39","author":"WD Clements","year":"1996","unstructured":"Clements WD, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ (1996) Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 39:587\u2013593","journal-title":"Gut"},{"key":"4054_CR56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-8278(88)80514-2","volume":"7","author":"T Boekhorst te","year":"1988","unstructured":"te Boekhorst T, Urlus M, Doesburg W, Yap SH, Goris RJ (1988) Etiologic factors of jaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J Hepatol 7:111\u2013117","journal-title":"J Hepatol"},{"key":"4054_CR57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ncpgasthep0796","volume":"4","author":"BA Carter","year":"2007","unstructured":"Carter BA, Shulman RJ (2007) Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 4:277\u2013287","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"4054_CR58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJMoa1102662","volume":"365","author":"MP Casaer","year":"2011","unstructured":"Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G (2011) Early versus late parenteral nutrition in critically ill adults. New Engl J Med 365:506\u2013517","journal-title":"New Engl J Med"},{"key":"4054_CR59","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S2213-2600(13)70183-8","volume":"1","author":"G Hermans","year":"2013","unstructured":"Hermans G, Casaer MP, Clerckx B, G\u00fciza F, Vanhullebusch T, Derde S, Meersseman P, Derese I, Mesotten D, Wouters PJ, Van Cromphaut S, Debaveye Y, Gosselink R, Gunst J, Wilmer A, Van den Berghe G, Vanhorebeek I (2013) Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621\u2013629","journal-title":"Lancet Respir Med"},{"key":"4054_CR60","doi-asserted-by":"crossref","unstructured":"Vanwijngaerden Y-M, Langouche L, Brunner R, Debaveye Y, Gielen M, Casaer M, Liddle C, Coulter S, Wouters PJ, Wilmer A, Van den Berghe G, Mesotten D (2013) Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge. Hepatology ;60:202\u2013610","DOI":"10.1002\/hep.26928"},{"key":"4054_CR61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G Berghe Van den","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. New Engl J Med 354:449\u2013461","journal-title":"New Engl J Med"},{"key":"4054_CR62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Berghe Van den","year":"2001","unstructured":"Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. New Engl J Med 345:1359\u20131367","journal-title":"New Engl J Med"},{"key":"4054_CR63","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/cc12606","volume":"17","author":"FA Gonnert","year":"2013","unstructured":"Gonnert FA, Recknagel P, Hilger I, Claus RA, Bauer M, Kortgen A (2013) Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model. Crit Care 17:R67","journal-title":"Crit Care"},{"key":"4054_CR64","doi-asserted-by":"crossref","first-page":"e1001338","DOI":"10.1371\/journal.pmed.1001338","volume":"9","author":"P Recknagel","year":"2012","unstructured":"Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, Dyson A, Carr\u00e9 JE, Kortgen A, Krafft C, Popp J, Sponholz C, Fuhrmann V, Hilger I, Claus RA, Riedemann NC, Wetzker R, Singer M, Trauner M, Bauer M (2012) Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 9:e1001338","journal-title":"PLoS Med"},{"key":"4054_CR65","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/jps.23584","volume":"102","author":"K Yang","year":"2013","unstructured":"Yang K, K\u00f6ck K, Sedykh A, Tropsha A, Brouwer KLR (2013) An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 102:3037\u20133057","journal-title":"J Pharm Sci"},{"key":"4054_CR66","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","volume":"51","author":"C Lammert","year":"2010","unstructured":"Lammert C, Bjornsson E, Niklasson A, Chalasani N (2010) Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 51:615\u2013620","journal-title":"Hepatology"},{"key":"4054_CR67","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.112.105775","volume":"126","author":"T Maruhashi","year":"2012","unstructured":"Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Tomiyama H, Takase B, Yamashina A, Higashi Y (2012) Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 126:598\u2013603","journal-title":"Circulation"},{"key":"4054_CR68","doi-asserted-by":"crossref","first-page":"e42428","DOI":"10.1371\/journal.pone.0042428","volume":"7","author":"\u00c1 Castilho","year":"2012","unstructured":"Castilho \u00c1, Aveleira CA, Leal EC, Sim\u00f5es NF, Fernandes CR, Meirinhos RI, Baptista FI, Ambr\u00f3sio AF (2012) Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative\/nitrosative stress-induced toxicity. PLoS One 7:e42428","journal-title":"PLoS One"},{"key":"4054_CR69","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1073\/pnas.252626999","volume":"99","author":"DE Baranano","year":"2002","unstructured":"Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093\u201316098","journal-title":"Proc Natl Acad Sci USA"},{"key":"4054_CR70","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.20334","volume":"40","author":"WW Wang","year":"2004","unstructured":"Wang WW, Smith DLH, Zucker SD (2004) Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40:424\u2013433","journal-title":"Hepatology"},{"key":"4054_CR71","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/01.CIR.102.24.3015","volume":"102","author":"P Wiesel","year":"2000","unstructured":"Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, Maemura K, LeBlanc BW, Marino K, Doerschuk CM, Yet SF, Lee ME, Perrella MA (2000) Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102:3015\u20133022","journal-title":"Circulation"},{"key":"4054_CR72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2009.10.037","volume":"52","author":"AD McNeilly","year":"2010","unstructured":"McNeilly AD, Macfarlane DP, O\u2019Flaherty E, Livingstone DE, Miti\u0107 T, McConnell KM, McKenzie SM, Davies E, Reynolds RM, Thiesson HC, Sk\u00f8tt O, Walker BR, Andrew R (2010) Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol 52:705\u2013711","journal-title":"J Hepatol"},{"key":"4054_CR73","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","volume":"368","author":"E Boonen","year":"2013","unstructured":"Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaerden YM, Spriet I, Wouters PJ, Vander Perre S, Langouche L, Vanhorebeek I, Walker BR, Van den Berghe G (2013) Reduced cortisol metabolism during critical illness. New Engl J Med 368:1477\u20131488","journal-title":"New Engl J Med"},{"key":"4054_CR74","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484\u2013489","journal-title":"Nature"},{"key":"4054_CR75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","volume":"329","author":"S Katsuma","year":"2005","unstructured":"Katsuma S, Hirasawa A, Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386\u2013390","journal-title":"Biochem Biophys Res Commun"},{"key":"4054_CR76","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.mcg.0000225593.93577.64","volume":"41","author":"M Alsatie","year":"2007","unstructured":"Alsatie M, Kwo PY, Gingerich JR, Qi R, Eckert G, Cummings OW, Imperiale TF (2007) A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C. J Clin Gastroenterol 41:416\u2013421","journal-title":"J Clin Gastroenterol"},{"key":"4054_CR77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","volume":"28","author":"I Kim","year":"2007","unstructured":"Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ (2007) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940\u2013946","journal-title":"Carcinogenesis"},{"key":"4054_CR78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.22342","volume":"48","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Xu P, Park K, Choi Y, Moore DD, Wang L (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48:289\u2013298","journal-title":"Hepatology"},{"key":"4054_CR79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.27338","volume":"61","author":"E Lang","year":"2015","unstructured":"Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C, Orth HM, Klindt C, Schuier M, Keitel V, Reich M, Liu G, Schmidt S, Xu HC, Qadri SM, Herebian D, Pandyra AA, Mayatepek E, Gulbins E, Lang F, Haussinger D, Lang KS, Foller M, Lang PA (2015) Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 61:275\u2013284","journal-title":"Hepatology"},{"key":"4054_CR80","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/ALN.0b013e3182104956","volume":"114","author":"LQ Yang","year":"2011","unstructured":"Yang LQ, Tao KM, Liu YT, Cheung CW, Irwin MG, Wong GT, Lv H, Song JG, Wu FX, Yu WF (2011) Remifentanil preconditioning reduces hepatic ischemia-reperfusion injury in rats via inducible nitric oxide synthase expression. Anesthesiology 114:1036\u20131047","journal-title":"Anesthesiology"},{"key":"4054_CR81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jss.2013.02.058","volume":"183","author":"G Zhao","year":"2013","unstructured":"Zhao G, Shen X, Nan H, Yan L, Zhao H, Yu J, Lv Y (2013) Remifentanil protects liver against ischemia\/reperfusion injury through activation of anti-apoptotic pathways. J Surg Res 183:827\u2013834","journal-title":"J Surg Res"},{"key":"4054_CR82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","volume":"3","author":"U Beuers","year":"2006","unstructured":"Beuers U (2006) Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3:318\u2013328","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"4054_CR83","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/01.CCM.0000215112.84523.F0","volume":"34","author":"JE Zimmerman","year":"2006","unstructured":"Zimmerman JE, Kramer AA, McNair DS, Malila FM (2006) Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today\u2019s critically ill patients. Crit Care Med 34:1297\u20131310","journal-title":"Crit Care Med"},{"key":"4054_CR84","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Gall Le","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963","journal-title":"JAMA"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-015-4054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-015-4054-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-015-4054-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T16:22:41Z","timestamp":1567182161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-015-4054-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["4054"],"URL":"https:\/\/doi.org\/10.1007\/s00134-015-4054-0","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]}}}